“novartis” Archives

in
Entry Author Date Location
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More 04/19/19 National
It’s Tough to Find Drugs to Bind to RNA: Arrakis Nabs $75M to Help 04/18/19 Boston
$100M for Talaris Gives Surgeon a Shot to Reinvent Organ Transplants 04/18/19 Boston
Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon 04/15/19 New York
How an Ohio Kids’ Hospital Quietly Became Ground Zero for Gene Therapy 04/15/19 National
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More 04/05/19 National
Report: Biogen, Novartis Should Drop Prices of Billon-Dollar SMA Drugs 04/04/19 Boston
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results 04/03/19 National
Novartis Adds Inflammation Drugs to Pipeline with Deal for IFM Tre 04/01/19 Boston
Xealth Gets $11M, Aims to Be Surescripts of Digital Health Services 03/27/19 Seattle
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Clinical Analytics Platform TriNetX Raises $40M to Speed Drug Trials 03/13/19 Boston
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
Precision Bio Preps IPO to Test “Off-the-Shelf” Cancer Cell Therapy 03/04/19 Raleigh Durham
After AGTC Deal Flops, Biogen Bets $800M on Gene Therapy Rival Nightstar 03/04/19 Boston
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark 03/01/19 National
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans 02/28/19 San Francisco
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away 02/26/19 National
Novartis to Pay $150M to Ionis, Akcea for Drug to Slow Heart Disease 02/25/19 San Diego
TCR²’s IPO Raises $75M to Bring Cancer Cell Therapy to Solid Tumors 02/14/19 Boston
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More 02/01/19 National
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy 01/31/19 New York
Aduro Biotech Slashes Staff 37%, Turns Focus to Lead Cancer Drugs 01/30/19 San Francisco
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More 01/11/19 National
Pfizer, GSK to Merge Consumer Health Units, Focus on Prescription Drugs 12/19/18 National
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2) 12/18/18 National
Merck Beefs Up Animal Health Unit with $2.4B Antelliq Acquisition 12/14/18 New York
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More 12/14/18 National
Pear Therapeutics App Gets FDA Nod for Treating Opioid Abuse 12/11/18 Boston
Bio Roundup: ASH Wrap, CRISPR Baby Fallout, Moderna’s Record IPO 12/07/18 National
Page 1 of 23 next page »